[Remote prognosis of tuberculous meningitis in children, with a follow-up of from four to six and a half years].
D010131:Aminosalicylic Acid / Q000627:therapeutic use*; D002648:Child; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D011379:Prognosis; D013307:Streptomycin / Q000627:therapeutic use*; D013450:Sulfones / Q000627:therapeutic use*; D014376:Tuberculosis; D014390:Tuberculosis, Meningeal
D013450:Sulfones; D010131:Aminosalicylic Acid; D013307:Streptomycin
PARA-AMINOSALICYLIC ACID/therapeutic use; STREPTOMYCIN/therapeutic use; SULFONES/therapeutic use; TUBERCULOSIS, MENINGEAL/in infant and child
Le pronostic éloigné de la méningite tuberculeuse de l'enfant avec un recul de quatre ans à six et demi.